Insilico Medicine

Generative AI platform for end-to-end drug discovery, from target identification to clinical trials

Enterprise·Technical·Powered by Insilico Medicine (proprietary LLLMs)·API available

Key strengths

End-to-end AI-driven drug discovery pipeline (target ID to clinical trials)Generative chemistry and biology AI (Chemistry42, Generative Biologics)Large Language of Life Models (LLLMs) for biomedical researchValidated therapeutic pipeline with programs in Phase I/II trialsMulti-modal platform covering disease modeling, molecule generation, and clinical prediction

Enterprise pricing

Cambridge, USA

Founded 2014

Get alerts when Insilico Medicine changes

Free. We'll email you when pricing, the free tier, API access or open-source status changes.

No ratings yet

Technical Integration & Developer Reference

Platform Modules

Module	Function	Key Technology
PandaOmics	Multi-omics target discovery & disease modeling	Graph neural networks, multi-omics data fusion
Chemistry42	Generative small molecule design & optimization	Reinforcement learning, generative adversarial networks
Generative Biologics	AI-designed biologic therapeutics	Protein language models, structure prediction
inClinico	Clinical trial success prediction	Transformer-based outcome models
Science42:DORA	LLM research assistant	Large Language of Life Models (LLLMs)

Licensing & API Access

Platform modules are available for enterprise licensing; contact Insilico for API credentials and integration documentation.
Benchmarks and evaluation datasets are published at Insilico Bench and the Drug Discovery Benchmark for reproducible third-party validation.

MMAI Gym

Provides standardized environments and benchmarks for training and evaluating AI models in drug discovery contexts, enabling researchers to compare methods against Insilico's published results.

Security & Compliance

Insilico maintains dedicated Security & IT governance documented on their site; enterprise deployments include data privacy controls suitable for proprietary compound libraries and clinical data.

Alternatives